Replay: How Can Myeloma Patients Learn About New Treatments?

Published on

Topics include: Treatment and Understanding

Program Guide (PDF)

Before making a confident treatment decision, multiple myeloma patients need sound, up-to-date information on their options from reliable sources. As a patient, how do I stay informed about new treatments in development? What are the considerations when choosing treatment that’s right for me? Hear from a panel of myeloma experts, including Dr. Amrita Krishnan from City of Hope, Dr. Joshua Richter from Mount Sinai School of Medicine, and Kristen Carter, an Advanced Practice Nurse at The UAMS Myeloma Institute, as they discuss trusted resources for learning about treatment options and how to make sense of the information. The panel also explains how new myeloma therapies are approved and the major medical conferences where treatment news is released. 

This is a Patient Empowerment Network program produced by Patient Power. We thank AbbVie, Inc., Celgene Corporation, and Takeda Oncology for their support.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

View more programs featuring , , and

Produced in association with

Related Programs

Is It Safe to Travel During Myeloma Treatment?

In this Patient Power replay, Host Andrew Schorr asks experts Dr. Larry Anderson Jr. and Dr. Robert Orlowski about how patients can continue to travel during myeloma treatment.

Published:

BCMA Biomarker Update: What Can One Drop of Blood Reveal About Your Myeloma?

What can one drop of blood reveal about your myeloma? Patient Power Founder, Andrew Schorr, is joined by myeloma expert Dr. James Berenson at ASCO 2018 to discuss the latest developments in biomarkers to evaluate change in clinical status.

Published:

Cherie Rineker: Post-CAR T-Cell Trial for Multiple Myeloma

Myeloma patient Cherie Rineker gives Patient Power an inside look into her experience with a CAR T-cell clinical trial. Watch to learn her highs and lows of the trial.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on July 31, 2018